Cancer genomic data sharing is a core pillar of precision oncology, underpinning reproducibility, scalability, and equity. The ability to discover, access, integrate, interpret, and reuse cancer 'omics data is a key determinant of precision oncology's value and benefit at scale. This work has been conducted as part of...
D. Torrents, Oliver Hofmann, K. Cranston et al.· EBioMedicine· 1 citation
A narrative review summarizes the clinicopathological features of HER2-altered NSCLC, critically evaluates emerging HER2-targeted therapies, and discusses future treatment directions.
Oscar Arrieta, E. Caballé-Pérez, L. Cabrera-Miranda et al.· Critical reviews in oncology...· 0 citations
The Commission developed a value-based resource-stratified implementation framework, a system-readiness assessment tool, a precision oncology workforce competency-based framework, a precision oncology monitoring and evaluation framework, and principles for responsible data sharing and health-system learning.
R. Casolino, J. Mateo, E. D. de Vries et al.· The Lancet Oncology· 11 citations
A descriptive analysis of oncology trials registered on ClinicalTrials.gov is presented and strategies to enhance international collaboration and amplify LMIC participation in setting global cancer research priorities are proposed.
O. Arrieta, E. Rios-Garcia, Cittim B. Palomares-Palomares et al.· The Oncologist· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
